EP
DNA icon

Essential Partners’s Ginkgo Bioworks DNA Stock Holding History

Essential Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.57K Sell
461
-2,584
-85% -$21.6K ﹤0.01% 1587
2026
Q1 		$18.7K Buy
3,045
+2,996
+6,114% +$24.9K 0.01% 953
2025
Q4 		$407 Buy
49
+8
+20% +$86 ﹤0.01% 2274
2025
Q3 		$598 Buy
41
+1
+3% +$12 ﹤0.01% 2163
2025
Q2 		$450 Buy
+40
New +$310 ﹤0.01% 1731

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Essential Partners's DNA Position: Q2 2026 in Review

Essential Partners reduced its Ginkgo Bioworks (DNA) stake by 85% in Q2 2026, selling an estimated $21.6K and leaving 461 shares worth $4.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1587.

Essential Partners first reported a position in DNA in Q2 2025 and has held it in 5 quarters since. The position peaked at $18.7K in Q1 2026. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Essential Partners held 461 shares of Ginkgo Bioworks worth $4.57K as of Q2 2026.
  • Essential Partners sold 2,584 Ginkgo Bioworks shares in Q2 2026, an estimated $21.6K.
  • Ginkgo Bioworks made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1587 holding.
  • Essential Partners first reported a position in Ginkgo Bioworks in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Ginkgo Bioworks position peaked at $18.7K in Q1 2026.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.